Send mail to Author

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___      _  __    _____    __   _    __   __  
| |  | ||   / _ \\   | |/ //  |  ___|| | || | ||  \ \\/ // 
| |/\| ||  | / \ ||  | ' //   | ||__   | '--' ||   \ ` //  
|  /\  ||  | \_/ ||  | . \\   | ||__   | .--. ||    | ||   
|_// \_||   \___//   |_|\_\\  |_____|| |_|| |_||    |_||   
`-`   `-`   `---`    `-` --`  `-----`  `-`  `-`     `-`'
 


Back to frontdoor view

OPUS4 Logo